about
Temporal distribution of tuberculosis in the State of Amazonas, BrazilMycobacterium tuberculosis infection in young children: analyzing the performance of the diagnostic tests.Whole genome sequencing distinguishes between relapse and reinfection in recurrent leprosy cases.Postgenomic approach to identify novel Mycobacterium leprae antigens with potential to improve immunodiagnosis of infection.Phage display and synthetic peptides as promising biotechnological tools for the serological diagnosis of leprosy.Factors associated with tuberculosis treatment default in an endemic area of the Brazilian Amazon: a case control-studyImpact of PGL-I seropositivity on the protective effect of BCG vaccination among leprosy contacts: a cohort studyDescription of leprosy classification at baseline among patients enrolled at the uniform multidrug therapy clinical trial for leprosy patients in Brazil.Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).[Factors associated with TB/HIV coinfection: evidence from notification data in the State of Amazonas, Brazil, 2001-2012].Increased sensitivity in diagnosis of tuberculosis in HIV-positive patients through the small-membrane-filter method of microscopy.Serology with ML Flow test in health professionals from three different states of Brazil.Leprosy serology using PGL-I: a systematic review.The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas.Seroprevalence of ML Flow test in leprosy contacts from State of Minas Gerais, Brazil.Use of ML dipstick as a tool to classify leprosy patients.Simple dipstick assay for semi-quantitative detection of neopterin in sera.The use of whole blood in a dipstick assay for detection of antibodies to Mycobacterium leprae: a field evaluation.The additional benefit of the ML Flow test to classify leprosy patients.The relation between seroprevalence of antibodies against phenolic glycolipid-I among school children and leprosy endemicity in Brazil.The ML flow test as a point of care test for leprosy control programmes: potential effects on classification of leprosy patients.Primary drug resistance among pulmonary treatment-naïve tuberculosis patients in Amazonas State, Brazil.Multidrug-resistant tuberculosis in the Amazonas State, Brazil, 2000-2011.Primary multidrug-resistant tuberculosis and its control implications in the State of Amazonas, Brazil: report of 3 cases.Risk factors for ML Flow seropositivity in leprosy patients.The influence of ML Flow test in leprosy classification.Seroreactivity to new Mycobacterium leprae protein antigens in different leprosy-endemic regions in Brazil.Evaluation of a rapid serological test for leprosy classification using human serum albumin as the antigen carrier.Could Mycobacterium leprae Infection Be an Occupational Disease? A Survey in Healthcare Workers From an Endemic Area in the Amazonian Region.Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients.A clinical trial for uniform multidrug therapy for leprosy patients in Brazil: rationale and design.Primary results of clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): reactions frequency in multibacillary patients.Evaluation of new strategies for the diagnosis of tuberculosis among pediatric contacts of tuberculosis patients.Historical analysis of the records of sylvan yellow fever in the State of Amazonas, Brazil, from 1996 to 2009.Patient profile and treatment satisfaction of Brazilian leprosy patients in a clinical trial of uniform six-month multidrug therapy (U-MDT/CT-BR).Association of the ML Flow serologic test to slit skin smear.Evaluation of the agreement between clinical and laboratorial exams in the diagnosis of leprosy.Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.Tuberculosis infection control: potential benefit of a new rapid tuberculosis test in a human immunodeficiency virus/AIDS reference hospital.Correlation between ELISA and ML Flow assays applied to 60 Brazilian patients affected by leprosy.
P50
Q28084685-160246B8-25ED-46B0-8E9D-6E8A0535DFC1Q33690038-172AB767-124C-48F3-A555-046D404ED9A4Q33690038-66D7C653-185D-44D5-974E-8EB6EAA084B6Q33874225-0DC758F3-B2AB-4B1E-9E59-54114A2EBF5BQ34034065-DD7023C0-4E34-4BD2-8EF2-375B8D6DDB4DQ34110480-E4A13C55-F90A-4B06-8604-ABAE5B8C30C9Q34312188-F988DB9C-2ADD-464D-AAE6-FAB6A0FA679EQ34314529-3A222163-8AB2-4238-BEFF-0ABA4F2F4291Q35692562-3126B261-6F00-470B-A3EE-CE0AF59C1A1CQ36286311-8FF33C67-BC8E-427A-8337-64A00AA4EF93Q36405541-6250E3FF-8FC6-46C2-99BC-0DE499D7BC79Q37125137-FBB733C0-C6E5-4635-8BB1-20768AA7D7F4Q37509436-5BB76C2A-4481-43DC-B9A3-0BB5DE8BE7C2Q37556044-01AE52CA-DB7E-447A-8183-A7932786ABB6Q38444605-24600751-9F71-4C41-9B67-EAF757BE7433Q38875078-68739D21-D171-4103-A792-E17039F945ACQ38925294-EC101F42-66B7-4123-9029-DD92530F8834Q38928064-4061CE2C-7E34-43DA-AFB2-B9A296AA825FQ38928067-13CE2F8D-9B9A-4737-832C-EEBE95D89703Q38928072-4FDAD640-46BF-443F-A6DC-91DE49BD9BCAQ38928076-8D0911AE-8A18-4405-A99F-004F54CCA990Q38928080-DEE99215-3857-452A-A26D-16071CD72232Q38959669-0A57155F-89B6-42F6-A738-DD7A31178A36Q39018315-0BBBB879-7503-4CDD-A4A9-4E443DC487BFQ39018321-C8E3D553-EE46-4BA0-BA94-D14521179952Q39034227-ABC8FBF2-2320-45B1-862B-2D7623536F4DQ39034230-3BF00A86-C188-45F5-AA94-FAE8A0CC00DEQ39088060-8F9B83F4-673D-4D73-B320-51ABE68E294AQ39275513-A26C8BA1-E602-489F-B619-A842301771E9Q39332732-99282EF5-2B10-4C4F-905A-4CF46CB529DEQ39348293-CE1D6EE0-68FF-4020-A4AF-844C6E60062CQ39348299-AA0AEC54-9C57-4FB3-B381-4ABD976DF5CAQ39348320-B5E0FD95-CDE3-44A4-8848-9DE55AACD377Q39372810-97F28139-42BD-4746-A73C-954CC19C39BAQ39430896-5AADBCA4-2A44-45BE-BF75-7BAA3FC40902Q41444743-2F2A5FC8-DA33-4EBE-8BB1-CC2C9CA904F6Q43307596-2B9A6D9B-5191-4229-9A5D-B67B2C981CCCQ43307600-D32F0CE6-2D27-48D3-A59F-FAECFE0E6EDCQ44527124-7308B1E1-F568-46C8-B3D5-26FAC5367041Q45345707-09B7DC44-AA5F-44BF-87C2-25E5BC004131
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samira Bührer-Sékula
@ast
Samira Bührer-Sékula
@en
Samira Bührer-Sékula
@es
Samira Bührer-Sékula
@nl
Samira Bührer-Sékula
@sl
type
label
Samira Bührer-Sékula
@ast
Samira Bührer-Sékula
@en
Samira Bührer-Sékula
@es
Samira Bührer-Sékula
@nl
Samira Bührer-Sékula
@sl
prefLabel
Samira Bührer-Sékula
@ast
Samira Bührer-Sékula
@en
Samira Bührer-Sékula
@es
Samira Bührer-Sékula
@nl
Samira Bührer-Sékula
@sl
P106
P21
P31
P496
0000-0002-5984-7770